DCF — HONORHEALTH DEER VALLEY MED CTR
Enterprise Value: $54.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$54.1M
Enterprise Value
$6.3M
PV of Cash Flows
$47.8M
PV of Terminal Value
$77.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $383.3M | $14.6M | 4.0% | $-2.9M | $-2.6M |
| Year 2 | $394.8M | $19.0M | 5.0% | $-0.0M | $-0.0M |
| Year 3 | $406.6M | $23.6M | 6.0% | $3.0M | $2.3M |
| Year 4 | $418.8M | $26.4M | 6.0% | $4.7M | $3.2M |
| Year 5 | $431.4M | $28.3M | 7.0% | $5.6M | $3.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $54.1M. Terminal value accounts for 88% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$372.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.033008999538616114
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5